UBS AG SEC Filings

UBS AG reported strong interim results for the six months ended 30 June 2026. Total revenues reached USD 27,510m, up from 23,798m a year earlier, and net profit attributable to shareholders rose to USD 4,713m from 2,220m. Return on equity improved to 10.5%, while the cost/income ratio fell to 77.1%, supported by higher income with broadly stable operating expenses.

As of 30 June 2026, total assets were USD 1,707,065m. Common equity tier 1 capital was USD 71,637m, giving a CET1 ratio of 14.3% and a going concern capital ratio of 18.9%. Total loss-absorbing capacity was USD 188,540m, a 37.7% ratio versus a required 26.10%. Liquidity remained high, with a liquidity coverage ratio of 172.5% and a net stable funding ratio of 114.7%. Invested assets increased to USD 7,326bn from 6,618bn, while headcount decreased to 59,594 full-time equivalents from 62,958.

In the second quarter of 2026, UBS AG consolidated earned net profit of USD 2,224m, compared with 2,811m at the UBS Group consolidated level, mainly due to purchase price allocation effects from the 2023 Credit Suisse acquisition and service markups from UBS Business Solutions subsidiaries. From 2026, UBS provides full IAS 34 interim financial statements semi-annually, with first- and third-quarter reports prepared under its accounting policies but with fewer disclosures.

UBS Group reported strong second‑quarter 2026 results while advancing the Credit Suisse integration. Reported net profit was 2.8 billion, earnings per share 87 cents, and underlying pre‑tax profit 3.9 billion, up 45% year on year. Revenues rose 16% to 13.3 billion, producing a 16.4% return on CET1 capital and a 70% cost‑income ratio as operating leverage improved. Cumulative gross cost savings since 2022 reached 12.6 billion, more than 90% of the 13.5 billion year‑end 2026 target.

Group invested assets reached a record 7.3 trillion, supported by 36 billion of net new assets in Global Wealth Management, 6 billion of net new money in Asset Management, and record Investment Bank second‑quarter revenues of 3.7 billion with over 23% pre‑tax ROE. The balance sheet totaled 1.7 trillion of assets with a 14.4% CET1 capital ratio, 115% net stable funding ratio and 177% liquidity coverage ratio, which management described as a “balance sheet for all seasons.” UBS announced a new share repurchase program of 3 billion dollars to be completed by the end of the second quarter 2027, with at least 1 billion planned over the next three months, subject to profitability, maintaining a CET1 ratio around 14% and Swiss capital discussions. Executives said first‑half performance leaves the firm well positioned to outperform its 2026 exit‑rate return target and achieve its cost‑income goal.

UBS Group AG provides updated consolidated capitalization data in US dollars under IFRS Accounting Standards as of 30 June 2026. Total capitalization was 432,981 USD m, composed of 343,551 USD m of debt issued, 89,165 USD m of equity attributable to shareholders, and 265 USD m of equity attributable to non-controlling interests. As context, total capitalization was 436,424 USD m as of 31 March 2026. As of 30 June 2026, 88% of debt issued was unsecured. This capitalization information is incorporated by reference into UBS Group’s existing Form F-3 and multiple Form S-8 registration statements and all prospectuses outstanding under them.

UBS Group AG presents standalone interim results for the six months ended 30 June 2026 under the Swiss Code of Obligations. Operating income was USD 7,936m, mainly from dividend income of USD 4,862m from subsidiaries, including USD 4,500m from UBS. Net profit for the period was USD 4,899m (CHF 3,962m), compared with USD 6,625m a year earlier.

At 30 June 2026, total assets were USD 206,432m and equity attributable to shareholders was USD 69,763m. Shareholders approved an ordinary cash dividend of USD 1.10 per share, totaling USD 3,404m, with the remaining USD 11,368m of prior-year profit appropriated to the voluntary earnings reserve. The Annual General Meeting also approved cancellation of 63,776,550 shares repurchased under the 2024 share repurchase program, reducing share capital by USD 6m and decreasing both the capital contribution reserve and voluntary earnings reserve by USD 997m each, while leaving total equity unchanged.

UBS Group AG reported second-quarter 2026 total revenues of USD 13.7bn and net profit attributable to shareholders of USD 2.8bn, with net profit growth of 16.9% year on year. Operating profit before tax rose 64% to USD 3.6bn, and the cost / income ratio improved to 72.9% (underlying 70.0%).

The integration of Credit Suisse is in its final phase: cumulative gross cost savings reached USD 12.6bn versus an ambition of approximately USD 13.5bn by year-end 2026, while cumulative integration-related expenses totaled USD 14.2bn. Non-core and Legacy operating expenses are down 88% versus 2022 and risk-weighted assets have fallen 68%, with credit and market risk RWA at USD 4bn. Capital and liquidity remain strong, with a CET1 ratio of 14.4%, total loss-absorbing capacity ratio of 38.4%, liquidity coverage ratio of 177.3% and net stable funding ratio of 115.1%. UBS completed a prior buyback and has reserved USD 3bn of CET1 capital for a new share repurchase program, planning to repurchase at least USD 1bn over the next three months.

UBS AG is issuing $570,000 of Trigger Autocallable Contingent Yield Notes linked to Lam Research Corporation common stock, maturing July 21, 2028. The Notes pay a high contingent coupon only if the stock’s closing level on each observation date is at or above a specified coupon barrier.

The Notes are automatically called if the stock is at or above the initial level on any observation date before maturity, in which case investors receive the $10 principal per Note plus the applicable contingent coupon and no further payments. If not called and the final level is at or above the downside threshold, investors receive full principal back (and a final coupon if the barrier is met).

If the Notes are not called and the final level is below the downside threshold, repayment is reduced dollar-for-dollar with the stock’s decline from the initial level, via $10 × (1 + underlying return), and investors can lose their entire investment. Any payments depend on the creditworthiness of UBS, the Notes are not insured, and they will not be listed on any exchange. Minimum investment is 100 Notes at $10 each, with an estimated initial value of $9.80 per Note.

UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Lam Research Corporation, maturing on or about July 21, 2028. Each Note has a $10 principal amount, with a minimum investment of 100 Notes (a $1,000 investment).

Investors receive a 32.88% per annum contingent coupon of $0.822 per period only when the Lam Research share price is at or above the coupon barrier of $50.00 (50% of the initial level) on an observation date. The Notes may be automatically called if the share price is at or above the initial level on any observation date before maturity, returning principal plus the due coupon. If not called and the final level is below the downside threshold of $50.00, repayment at maturity is reduced dollar-for-dollar with the stock’s negative performance, and investors can lose their entire investment. All payments depend on the creditworthiness of UBS.